Live
CellGenomic atlas of <em>Bifidobacterium infantis</em> and <em>B. longum</em> informs infant probiotic designFierceBiotechGenentech antibody fails to boost muscle in rare diseases, raising questions for obesity trialIlluminaIllumina and Labcorp Expand Precision Oncology Testing Partnership - OncodailyLonza NewsLonza Group AG stock under pressure on Swiss Exchange amid trade surplus data and CDMO pivot - AD HOC NEWSEndpoints NewsFDA seeks input on Makary's voucher pilotBioPharma DiveEarendil Labs, an AI-powered drugmaker, hauls in $787MBioWorldBiopharma money raised: Jan. 1-March 20, 2026BioWorldMoney raised by biopharmaEndpoints NewsTop HHS official tamps down expectations on scope of TrumpRxFierceBiotechChutes & Ladders—Eric Topol boards Flagship as advisorFierceBiotechBehind the curtain: What Xaira is building after its $1B fundraiseFierceBiotechIntuitive recalls surgical stapler reloads following patient death
FierceBiotech Mar 20, 2026

Genentech antibody fails to boost muscle in rare diseases, raising questions for obesity trial

Genentech antibody fails to boost muscle in rare diseases, raising questions for obesity trial

Original
Body unavailable. Use the original source.

Directory

59 All